$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$395.86B
Market Cap
169.68
P/E Ratio
1.32
EPS
$243.06
52 Week High
$160.33
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
AbbVie Inc is a leading American biopharmaceutical company, established in 2013 from a spin-off of Abbott Laboratories. The company specializes in the research, development, and commercialization of advanced therapies in immunology, oncology, virology, and neuroscience. With a robust pipeline of innovative treatments, AbbVie is committed to addressing some of the world's most challenging health issues and is recognized for its blockbuster immunology drug, Humira. AbbVie continues to strengthen its portfolio through strategic acquisitions and collaborations, positioning itself as a formidable player in the global biopharmaceutical landscape.
LPTX
KIND
NVDA
WOK
F
KAVL
ADAP
CGC
TLRY
TSLA
AVGO
NIO
ASST
PFE
PLTD
INTC
CDE
SNAP
MTSR
FI
APLT
HBAN
CCL
UBER
KO
WULF
SOUN
CAN
EOSE
MSTR
MU
CX
ASBP
RR
PLUG
MDLZ
NVTS
TSM
BYND
AMD
CLSK
SHOT
ZAPP
AG
RXRX
VALE
IVP
HL
ORCL
NBIS
PG
SPR
KMI
C
HOOD
PLTR
CVE
HPQ
HIMS
USB
CSX
LULU
FITB
RIG
LPTX
KIND
NVDA
WOK
F
KAVL
ADAP
CGC
TLRY
TSLA
AVGO
NIO
ASST
PFE
PLTD
INTC
CDE
SNAP
MTSR
FI
APLT
HBAN
CCL
UBER
KO
WULF
SOUN
CAN
EOSE
MSTR
MU
CX
ASBP
RR
PLUG
MDLZ
NVTS
TSM
BYND
AMD
CLSK
SHOT
ZAPP
AG
RXRX
VALE
IVP
HL
ORCL
NBIS
PG
SPR
KMI
C
HOOD
PLTR
CVE
HPQ
HIMS
USB
CSX
LULU
FITB
RIG